Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Glaucoma: Overview01:25

Glaucoma: Overview

528
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
528
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

454
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
454
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
413

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Primary Open-Angle Glaucoma Locus Near Transcription Factor <i>PRRX1</i> Identified in the Million Veteran Program.

Ophthalmology science·2026
Same author

Primary Open Angle Glaucoma Polygenic Risk Score is Associated with Disease Progression.

Ophthalmology. Glaucoma·2026
Same author

Pre-diagnostic plasma endogenous steroids and the risk of exfoliation glaucoma.

medRxiv : the preprint server for health sciences·2026
Same author

Whole-genome sequence genome-wide association study in <i>All of Us</i> identifies a novel glaucoma risk locus in African ancestry individuals.

medRxiv : the preprint server for health sciences·2026
Same author

Pro-Homeostatic Effects of Estrogen on Intraocular Pressure and the Trabecular Meshwork.

Investigative ophthalmology & visual science·2026
Same author

Uncovering the Genetic Architecture of Optic Nerve Integrity Estimates through Genome-wide Association Study Meta-analyses.

medRxiv : the preprint server for health sciences·2026
Same journal

Perimetric Outcomes of Melbourne Rapid Field Perimetry in Patients With Glaucoma: A Systematic Review and Meta-Analysis.

Journal of glaucoma·2026
Same journal

Rethinking Dry Eye and Ocular Surface Disease in Glaucoma: Pathophysiology, Diagnosis, and Management.

Journal of glaucoma·2026
Same journal

Outcome of Gonioscopy-Assisted Transluminal Trabeculotomy in Uveitic Glaucoma.

Journal of glaucoma·2026
Same journal

"Letter to the Editor: Myopic Shift Induced By Omidenepag Isopropyl 0.002% in Patients With Primary Open-Angle Glaucoma, Jan 2026.

Journal of glaucoma·2026
Same journal

Comparative Evaluation of Functional Aqueous Humor Outflow in Primary Open Angle Glaucoma versus Primary Angle Closure Glaucoma using Aqueous Angiography.

Journal of glaucoma·2026
Same journal

Patient and Neighborhood Factors Influencing Glaucoma Medication Adherence.

Journal of glaucoma·2026
查看所有相关文章

相关实验视频

Updated: Jun 16, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K

在眼病例检测中的技术和方法.

Louis R Pasquale1

  • 1Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY.

Journal of glaucoma
|August 16, 2024
PubMed
概括
此摘要是机器生成的。

使用手持工具进行青光眼查,由于疾病患病率低,因此成本效益不佳. 未来的战略包括使用生物标志物工具来增加查前的流行检测.

更多相关视频

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K

相关实验视频

Last Updated: Jun 16, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K

科学领域:

  • 眼科医生 眼科 眼科
  • 生物标志物 生物标志物
  • 公共卫生 公共卫生

背景情况:

  • 玻璃眼是全球不可逆转的失明的主要原因.
  • 目前的查方法面临成本效益方面的挑战,特别是在低患病率的人群中.
  • 早期发现青光眼对于预防视力丧失至关重要.

研究的目的:

  • 评估一种新的玻璃眼查策略的成本效益.
  • 探索一级生物标记器工具在提高青光眼的检测中的实用性.
  • 提出一种改进的方法来发现绿眼病例.

主要方法:

  • 该研究从概念上概述了一个两阶段的选过程.
  • 第1阶段涉及一级生物标志物工具,用于识别高风险个体.
  • 第二阶段使用手持查工具来确认高风险个体.

主要成果:

  • 由于疾病流行率较低,单一的查工具对于成本有效的青光眼检测是不够的.
  • 在查之前整合生物标记器工具可以显著提高检测率.
  • 这种分层的方法提供了一个潜在的更有效的策略,用于识别眼病例.

结论:

  • 结合生物标志物和查工具的方法为成本效益高的青光眼检测提供了一个有希望的未来战略.
  • 通过生物标志物提高疾病流行率估计是提高查效率的关键.
  • 这种模式可以优化对眼的公共卫生倡议的资源配置.